| JYSB2500112 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products | Supplementary Application | 2025-05-01 | | Novo Nordisk A/S | | | view |
| CYSB2500065 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2025-03-26 | | Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd;Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| CYSB2500064 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2025-03-26 | | Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd;Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| CXSS2400132 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-12-03 | | ChongQing Chenan Biopharmaceutical Co Ltd | | | view |
| CXHL2401290 | 利拉鲁肽注射液 | liraglutide | Injection | Chemical Drugs(2.2) | New Drug Application | 2024-11-28 | | Zhejiang Heze Pharmaceutical Technology Co Ltd | | | view |
| CXSL2400772 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-11-13 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| JYSZ2400055 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | License Renew | 2024-10-16 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
| CXHS2400103 | 利拉鲁肽注射液 | liraglutide | Injection | Chemical Drugs(2.2) | New Drug Application | 2024-10-13 | | Hybio Pharmaceutical Co Ltd | | | view |
| CXSL2400436 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-07-09 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| CXHL2400487 | 利拉鲁肽注射液 | liraglutide | Injection | Chemical Drugs(2.2) | New Drug Application | 2024-05-14 | | Zhejiang Heze Pharmaceutical Technology Co Ltd | | | view |
| JYSB2400059 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2024-03-14 | | Novo Nordisk A/S | | | view |
| JYSB2400035 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.1) | Supplementary Application | 2024-02-27 | | Novo Nordisk A/S | | | view |
| CXSL2400105 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-02-07 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CXSL2400082 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-02-01 | | Dongguan HEC Biopharmaceutical R&D Co Ltd;Sunshine Lake Pharma Co Ltd | | | view |
| JYSB2400021 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products | Supplementary Application | 2024-02-01 | | Novo Nordisk A/S | | | view |
| JYSB2400017 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2024-01-30 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
| JYSZ2300038 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | License Renew | 2023-09-13 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
| CXSS2300067 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2023-08-22 | | Zhuhai Federal Biomedical Co Ltd;Zhuhai United Laboratories Co Ltd | | | view |
| CXSL2300515 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2023-07-26 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| CXHL2300222 | 利拉鲁肽注射液 | liraglutide | Injection | Chemical Drugs(2.2) | New Drug Application | 2023-02-15 | | Zhejiang Heze Pharmaceutical Technology Co Ltd | | | view |
